“…Median sample size in these 71 quantitative studies was 224.5 (Interquartile Range 354). Most of the studies were conducted in breast cancer survivors (n = 25, 35.2%) [26,28,29,32,[35][36][37][38]40,[42][43][44]50,51,61,[64][65][66]68,70,80,87,90,93,94], five studies were conducted in prostate cancer survivors [73,74,85,89,92], six in colorectal cancer survivors [33,34,49,63,72,96], two in lung cancer survivors [52,95], two in head and neck cancer survivors [55,71], one in in thyroid cancer survivors [79], one in laryngology cancer survivors [54], one in endometrial cancer survivors [27], and one in hematologic cancer survivors [69]. 27 studies (38%) were conducted in survivors of mixed cancer types [30,31,…”